565
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Biochemical characterization of an ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat cardiac soluble and microsomal fractions

, , , &
Pages 29-36 | Received 15 Jul 2010, Accepted 18 Mar 2011, Published online: 03 May 2011

Figures & data

Figure 1.  Time course and protein concentration curves for p-Nph-5′-TMP hydrolysis. Time course in the soluble fraction was performed with 90 µg of protein; 30 µg of protein was used in microsomal fraction. In relation to protein concentration curves were used 40 and 6 min for p-Nph-5′-TMP hydrolysis in soluble and microsomal fractions, respectively. The plots are representative of three independent experiments for each fraction.

Figure 1.  Time course and protein concentration curves for p-Nph-5′-TMP hydrolysis. Time course in the soluble fraction was performed with 90 µg of protein; 30 µg of protein was used in microsomal fraction. In relation to protein concentration curves were used 40 and 6 min for p-Nph-5′-TMP hydrolysis in soluble and microsomal fractions, respectively. The plots are representative of three independent experiments for each fraction.

Figure 2.  Divalent cations dependence on p-Nph-5′-TMP hydrolysis. Hydrolysis of p-Nph-5′-TMP by rat cardiac soluble (A) and microsomal (B) fractions were analysed in the absence of cations (Control), in the presence of 0.025, 0.05 and 0.1 mM EDTA and in the presence of 2.0–8.0 mM Ca2+ or Mg2+. Bars represent means ± SD of three independent experiments. Results are expressed as nmol p-nitrophenol/min/mg of protein. *Significantly different from respective control group (P < 0.05).

Figure 2.  Divalent cations dependence on p-Nph-5′-TMP hydrolysis. Hydrolysis of p-Nph-5′-TMP by rat cardiac soluble (A) and microsomal (B) fractions were analysed in the absence of cations (Control), in the presence of 0.025, 0.05 and 0.1 mM EDTA and in the presence of 2.0–8.0 mM Ca2+ or Mg2+. Bars represent means ± SD of three independent experiments. Results are expressed as nmol p-nitrophenol/min/mg of protein. *Significantly different from respective control group (P < 0.05).

Figure 3.  Effect of pH on p-Nph-5′-TMP hydrolysis in rat cardiac soluble (A) and microsomal (B) fractions. Enzyme activity was determined as described in “Materials and methods” using a mixture of the following buffers: Tris and glycine (pH range 8.0 to 10.0). Data represent means ± SD of three different experiments. Results are expressed as nmol p-nitrophenol/min/mg of protein.

Figure 3.  Effect of pH on p-Nph-5′-TMP hydrolysis in rat cardiac soluble (A) and microsomal (B) fractions. Enzyme activity was determined as described in “Materials and methods” using a mixture of the following buffers: Tris and glycine (pH range 8.0 to 10.0). Data represent means ± SD of three different experiments. Results are expressed as nmol p-nitrophenol/min/mg of protein.

Figure 4.  Eadie–Hofstee plot for p-Nph-5′-TMP hydrolysis. The nucleotide hydrolysis as function of substrate concentration from rat cardiac soluble (A) and microsomal (B) fractions is shown in the insets. The mean KM values calculated for p-Nph-5′-TMP hydrolysis were found to be 118.5 ± 27.2 µM and 91.9 ± 12.4 µM, respectively, and Vmax value calculated in soluble and microsomal fractions were 2.52 ± 0.1 and 113.87 ± 21.1 nmol p-nitrophenol/min/mg, respectively. Data are expressed as mean ± SD, n = 4.

Figure 4.  Eadie–Hofstee plot for p-Nph-5′-TMP hydrolysis. The nucleotide hydrolysis as function of substrate concentration from rat cardiac soluble (A) and microsomal (B) fractions is shown in the insets. The mean KM values calculated for p-Nph-5′-TMP hydrolysis were found to be 118.5 ± 27.2 µM and 91.9 ± 12.4 µM, respectively, and Vmax value calculated in soluble and microsomal fractions were 2.52 ± 0.1 and 113.87 ± 21.1 nmol p-nitrophenol/min/mg, respectively. Data are expressed as mean ± SD, n = 4.

Table 1.  Effect of distinct compounds on p-nitrophenyl-5′-TMP hydrolysis from rat cardiac soluble and microsomal fractions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.